About a year ago, the Enlarged Board of Appeal issued its decision in G 1/22 (consolidated with G 2/22), which significantly relaxed the EPO’s approach to ‘same applicant’ priority Under… read more…
Commentary by Partner Edd Cavanna has been featured in Law360, World Intellectual Property Review, The Register and Communications Today discussing the global increase of semiconductor patent… read more…
Historically, women’s health has been greatly underfunded and under-researched Nowhere is this gender-biased neglect more evident than in the research and clinical management of menopause symptoms… read more…
Mathys & Squire have ranked in the 2025 Chambers and Partners UK Legal Guide, which acknowledges some of the top ranked law firms and lawyers each year The research analysts obtain information… read more…
In a much-anticipated decision, Technical Board of Appeal 3304 has held that there is no requirement under the EPC for an applicant to amend the description of a patent application before grant (T… read more…
In a surprise move, the representatives acting on behalf of UC Berkley defending CRISPR patents in appeal proceedings before the EPO have withdrawn their approval of the texts of the patents thereby… read more…
We are delighted to announce that Mathys & Squire has upheld its position in the 2025 edition of The Legal 500 for both PATMA: Patent Attorneys and PATMA: Trade Mark Attorneys categories… read more…
Managing IP have released their guide for the 2024 IP Rising Stars, which recognises the best up-and-coming practitioners across several IP areas and more than 50 jurisdictions Each year, the… read more…
Partner Nicholas Fox has been featured in the ‘’This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards’’ article by Sarah Speight… read more…